Takeda Pharmaceuticals U.S.A., Inc. (TPUSA) is among the top 25 largest pharmaceutical companies in the United States. Founded in 1998, as Takeda's largest business unit outside of Japan, the U.S. Business Unit continues to be a key contributor to our global growth and success. TPUSA focuses on oncology therapies, medicines for the central nervous system and gastroenterology, and vaccines that address some of the world's most pressing public health needs. Striving toward better health is at the center of everything we do.
Everything we do at Takeda starts with this question: How can we do more for our patients? We are guided towards an answer by focusing on – in this order – our four priorities:
1) Put the patient at the center
2) Build trust with society
3) Reinforce our reputation
4) Develop the business
Adhering to these priorities has been fundamental to how we've succeeded over the years, and is at the center of how we will continue to succeed going forward.